12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Company News  |  Deals

Concordia, Ono Pharmaceutical deal

Concordia granted Ono exclusive rights to develop and commercialize salirasib in Japan. The Ras antagonist has completed...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >